3D Diagnostic, a diagnostics spinout from Chinese tumor immunotherapy specialist 3D Medicines, has raised RMB1.5 billion ($224 million) in funding led by CPE, formerly known as CITIC Private Equity.
CICC Capital, local drug developer Jemincare, Tsing Song Capital, state-owned VC investor Spinnotec, a healthcare unit of electronic appliances manufacturer Haier, Ruiyi Investment, and LanShang Capital...
Yunwang Wandian, the e-commerce services arm of Suning.com, one of China’s largest retailers, has raised a RMB6 billion ($912 million) Series A round led by Shenzhen Capital Group.
Southeast Asia-focused private equity firm KV Asia Capital has exited TF Value Mart (TFVM), a Malaysia-based grocery retailer in which it has held a controlling stake since 2016, to Intermediate Capital Group (ICG).
NextGen Funds Management, a newly established GP in Australia, has launched what it is calling the country’s first dedicated artificial intelligence (AI) fund.
Hong Kong’s 3W Fund Management has led a $43 million Series E round for CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses cancer and rare diseases.